Kalyan Roy: Polycythaemia Rubra Vera – More Than Just Elevated Hemoglobin
Kalyan Roy, Transfusion Medicine Specialist at Square Hospitals LTD, shared a post on LinkedIn:
“Polycythaemia Rubra Vera (PV): More Than Just Elevated Hemoglobin
Polycythaemia Vera (PV) is a chronic JAK2 mutation–driven myeloproliferative neoplasm characterized by uncontrolled red blood cell production, often accompanied by leukocytosis and thrombocytosis. The resulting hyperviscosity syndrome significantly increases the risk of arterial and venous thrombosis, making early diagnosis and appropriate management essential.
Key Clinical Highlights
- JAK2 V617F mutation present in ~95–98% of cases
- Elevated hemoglobin, hematocrit, and red cell mass
- Common symptoms: headache, dizziness, visual disturbances, aquagenic pruritus, and erythromelalgi
- Increased risk of stroke, myocardial infarction, DVT, pulmonary embolism, and splanchnic vein thrombosi
- Low serum erythropoietin (EPO) is a characteristic laboratory finding
WHO Diagnostic Corner
Elevated Hb/Hct
Hypercellular bone marrow with trilineage proliferation
Presence of JAK2 mutation
Low serum EPO supports the diagnosis
Transfusion Medicine Perspective
Therapeutic Phlebotomy remains the cornerstone of treatment and the most important intervention performed by Transfusion Medicine services.
Treatment Goals:
- Maintain hematocrit <45%
- Reduce blood viscosity
- Prevent thrombotic complications
- Control symptoms and disease progression
Take-Home Message
Early recognition and optimal hematocrit control significantly reduce morbidity and mortality in PV. Therapeutic phlebotomy, antiplatelet therapy, and risk-adapted cytoreductive treatment remain the foundation of modern management.”

Find more posts featuring Kalyan Roy on Hemostasis Today.
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation
-
Nov 8, 2026, 05:34Eugene Bolotin: Thrombosis and Survival in Pancreatic Cancer